• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session

    9/7/22 12:22:21 PM ET
    $ALNA
    $AQST
    $ASO
    $AVCT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALNA alert in real time by email

    Gainers

    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares surged 44.3% to $4.7893 after Alliance Global Partners initiated coverage on the stock with a Buy rating and a $20 price target.
    • IMARA Inc. (NASDAQ:IMRA) rose 37% to $1.57 after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront.
    • Sidus Space, Inc. (NASDAQ:SIDU) gained 26.7% to $3.3701 after the company announced that it has signed a launch agreement with SpaceX for five launches, beginning in early 2023.
    • Cryo-Cell International, Inc. (NYSE:CCEL) jumped 17.7% to $7.86.
    • bioAffinity Technologies, Inc. (NASDAQ:BIAF) rose 19.7% to $6.45 after dropping around 24% on Tuesday. The company, last week, priced its IPO at $6.125 per unit.
    • Azure Power Global Limited (NYSE:AZRE) shares gained 17.3% to $4.21. Azure Power Global recently announced the resignation of Harsh Shah as CEO.
    • Pingtan Marine Enterprise Ltd. (NASDAQ:PME) jumped 17.3% to $0.8565.
    • Glaukos Corporation (NYSE:GKOS) gained 17.3% to $56.40 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary efficacy endpoints through 3 months in both Phase 3 trials and demonstrated excellent tolerability and a favorable safety profile through 12 months.
    • Aquestive Therapeutics, Inc. (NASDAQ:AQST) rose 16.8% to $1.4599. Oppenheimer initiated coverage on Aquestive Therapeutics with an Outperform rating and announced a price target of $8.5.
    • Spero Therapeutics, Inc. (NASDAQ:SPRO) shares rose 16.4% to $1.3150. Spero Therapeutics shares jumped over 55% on Tuesday after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr.
    • Biophytis S.A. (NASDAQ:BPTS) shares gained 16% to $1.0899 after the company released topline results from its phase 2-3 COVA study evaluating Sarconeos (BIO101) in treating COVID-19-related respiratory failure.
    • SelectQuote, Inc. (NYSE:SLQT) rose 15.4% to $1.2808.
    • Seres Therapeutics, Inc. (NASDAQ:MCRB) gained 14.2% to $6.16. Seres Therapeutics announced completion of rolling BLA submission to the FDA for investigational microbiome therapeutic SER-109 for recurrent C. Difficile infection.
    • Academy Sports and Outdoors, Inc. (NASDAQ:ASO) jumped 12% to $46.98. Academy Sports And Outdoors reported a second-quarter FY22 sales decline of 5.8% year-on-year to $1.69 billion.
    • Nutex Health, Inc. (NASDAQ:NUTX) jumped 11.5% to $2.90.
    • Unico American Corporation (NASDAQ:UNAM) gained 10.6% to $1.8580.
    • Coupa Software Incorporated (NASDAQ:COUP) rose 10.5% to $61.65 as the company posted better-than-expected results for its second quarter and issued strong forecast for FY23. The company also announced a $100 million buyback program.
    • Tempur Sealy International, Inc. (NYSE:TPX) jumped 8.2% to $26.39.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) gained 7.6% to $9.47.
    • Baudax Bio, Inc. (NASDAQ:BXRX) rose 7.6% to $0.3243 after declining over 7% on Tuesday. Baudax Bio recently announced the pricing of a $6.2 million public offering.


    Losers

    • Great Panther Mining Limited (NYSE:GPL) dropped 65% to $0.2801. Great Panther recently announced it will file a notice of intention to make a proposal under the Bankruptcy and Insolvency Act (Canada).
    • CleanTech Acquisition Corp. (NASDAQ:CLAQ) shares fell 36.4% to $6.03 after the company reported shareholder voting results in 8K filing.
    • NewAge, Inc. (NASDAQ:NBEV) shares dipped 25% to $0.0937 after dipping over 15% on Tuesday. The company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) fell 22.8% to $1.96.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares dipped 20.6% to $3.35 after jumping around 33% on Tuesday. First Wave BioPharma recently announced a 1:30 reverse stock split.
    • Presidio Property Trust, Inc. (NASDAQ:SQFT) fell 18.3% to $1.7001. Presidio Property Trust recently declared Q3 dividend and adopted variable dividend policy.
    • Golden Path Acquisition Corporation (NASDAQ:GPCO) dropped 17.5% to $8.46.
    • AMTD Digital Inc. (NYSE:HKD) dropped 16.4% to $57.63.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) declined 16.3% to $0.1842. American Virtual Cloud Technologies recently announced an equity distribution agreement to offer and sell up to $14.7 million shares of common stock.
    • UiPath Inc. (NYSE:PATH) fell 13.9% to $13.43 after the company issued Q3 and FY23 sales guidance below analyst estimates.
    • John Wiley & Sons, Inc. (NYSE:WLY) dropped 13.6% to $39.81 after the company reported worse-than-expected Q1 EPS and sales results.
    • Veru Inc. (NASDAQ:VERU) declined 13.5% to $12.62. Traders circulate word FDA decision on the company’s COVID treatment coming on Oct. 6.
    • FaZe Holdings Inc. (NASDAQ:FAZE) dipped 12.1% to $12.06.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) dropped 11% to $2.4289.
    • Vacasa, Inc. (NASDAQ:VCSA) fell 9.5% to $3.6450.
    • DBV Technologies S.A. (NASDAQ:DBVT) fell 8.5% to $2.15 after gaining around 8% on Tuesday. DBV Technologies, last month, posted a Q2 loss of $0.35 per share.
    • Korn Ferry (NYSE:KFY) fell 8.2% to $55.26 following downbeat quarterly earnings.
    • G-III Apparel Group, Ltd. (NASDAQ:GIII) dropped 5.6% to $18.73 after the company posted downbeat quarterly earnings and lowered FY23 forecast.
    • GameStop Corp. (NYSE:GME) fell 4.5% to $24.00 ahead of quarterly earnings.
    Get the next $ALNA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALNA
    $AQST
    $ASO
    $AVCT

    CompanyDatePrice TargetRatingAnalyst
    Veru Inc.
    $VERU
    12/18/2025$25.00Buy
    Canaccord Genuity
    DBV Technologies S.A.
    $DBVT
    12/15/2025$42.00Overweight
    Cantor Fitzgerald
    G-III Apparel Group LTD.
    $GIII
    12/10/2025$30.00 → $34.00Market Perform
    Telsey Advisory Group
    DBV Technologies S.A.
    $DBVT
    12/3/2025$35.00Buy
    Guggenheim
    Glaukos Corporation
    $GKOS
    10/27/2025$120.00Equal Weight → Overweight
    Wells Fargo
    G-III Apparel Group LTD.
    $GIII
    10/15/2025$32.00Buy
    BTIG Research
    UiPath Inc.
    $PATH
    10/2/2025$12.50 → $13.00Market Perform
    BMO Capital Markets
    Glaukos Corporation
    $GKOS
    10/1/2025$103.00Buy
    Goldman
    More analyst ratings

    $ALNA
    $AQST
    $ASO
    $AVCT
    SEC Filings

    View All

    SEC Form 424B3 filed by Mobile Global Esports Inc.

    424B3 - Mobile Global Esports, Inc. (0001886362) (Filer)

    2/23/26 7:52:02 AM ET
    $MGAM
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form EFFECT filed by Mobile Global Esports Inc.

    EFFECT - Mobile Global Esports, Inc. (0001886362) (Filer)

    2/23/26 12:15:12 AM ET
    $MGAM
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 10-K filed by Glaukos Corporation

    10-K - GLAUKOS Corp (0001192448) (Filer)

    2/20/26 7:54:50 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $ALNA
    $AQST
    $ASO
    $AVCT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Veru with a new price target

    Canaccord Genuity initiated coverage of Veru with a rating of Buy and set a new price target of $25.00

    12/18/25 9:11:57 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cantor Fitzgerald initiated coverage on DBV Technologies with a new price target

    Cantor Fitzgerald initiated coverage of DBV Technologies with a rating of Overweight and set a new price target of $42.00

    12/15/25 9:59:53 AM ET
    $DBVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Telsey Advisory Group reiterated coverage on G-III Apparel with a new price target

    Telsey Advisory Group reiterated coverage of G-III Apparel with a rating of Market Perform and set a new price target of $34.00 from $30.00 previously

    12/10/25 8:01:21 AM ET
    $GIII
    Apparel
    Consumer Discretionary

    $ALNA
    $AQST
    $ASO
    $AVCT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UiPath Launches Agentic AI Solutions to Break Administrative & Financial Bottlenecks for Clinicians and Healthcare Admins

    Offerings for medical records summarization, claim denial prevention and resolution, and prior authorization streamline payer/provider collaboration and dramatically reduce processing and payment delays Visit UiPath at ViVE 2026 in booth #1212 UiPath (NYSE:PATH), a global leader in agentic automation, today announced new agentic AI solutions for the healthcare industry for providers and payers at the ViVE 2026 conference. The offerings for medical records summarization, claim denial prevention and resolution, and prior authorization leverage agentic automation, business orchestration, and purpose-built, fully compliant and governed agents to connect data, improve efficiency, and acceler

    2/23/26 8:30:00 AM ET
    $PATH
    Computer Software: Prepackaged Software
    Technology

    TGE's Film "Scare Out" Exceeds US$120 Million at the Box Office in just 7 Days

    PARIS, NEW YORK and LONDON, Feb. 23, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE:AMTD, SGX: HKB)), AMTD Digital Inc. (NYSE:HKD) and The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE), a subsidiary of AMTD Digital Inc., jointly announce that "Scare Out" (the "Movie"), the first ever national‑security film co‑produced by TGE, captured a significant share of the box office during the Chinese New Year window. Featuring an all‑star cast including Jackson Yee, Yilong Zhu, Jia Song, Jiayin Lei, Mi Yang, Yi Zhang, Cecilia Liu, and Yaowen Liu, the Movie achieved box office inflows of over US$120 million within just its first seven days of release.

    2/23/26 8:20:00 AM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    Aquestive Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference

    WARREN, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the management team will participate in the upcoming Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25-26, which is a virtual event. The Aquestive team will be presenting on February 26th, at 12 pm ET; management will also be hosting one-on-ones with investors that same day. A webcast of the presentation will be available under the "Events and Presentations" page of the Inve

    2/23/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNA
    $AQST
    $ASO
    $AVCT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IDOSE TR issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug IDOSE TR (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/15/23 11:41:09 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    FDA Approval for TRAVOPROST issued to GLAUKOS CORP

    Submission status for GLAUKOS CORP's drug TRAVOPROST (ORIG-1) with active ingredient TRAVOPROST has changed to 'Approval' on 12/13/2023. Application Category: NDA, Application Number: 218010, Application Classification: Type 3 - New Dosage Form

    12/14/23 7:41:03 AM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    $ALNA
    $AQST
    $ASO
    $AVCT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT Grant Robert Clay bought $105,024 worth of shares (118,901 units at $0.88) (SEC Form 4)

    4 - SelectQuote, Inc. (0001794783) (Issuer)

    2/19/26 4:11:41 PM ET
    $SLQT
    Specialty Insurers
    Finance

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    President, CEO and Chairman Cohen Ryan bought $21,359,200 worth of shares (1,000,000 units at $21.36), increasing direct ownership by 3% to 38,347,842 units (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/22/26 4:02:03 PM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $ALNA
    $AQST
    $ASO
    $AVCT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Weisner Aimee S gifted 980 shares, received a gift of 980 shares, exercised 15,000 shares at a strike of $24.69 and sold $1,760,761 worth of shares (15,000 units at $117.38), decreasing direct ownership by 5% to 18,806 units (SEC Form 4)

    4 - GLAUKOS Corp (0001192448) (Issuer)

    2/23/26 5:24:44 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    PRESIDENT Grant Robert Clay bought $105,024 worth of shares (118,901 units at $0.88) (SEC Form 4)

    4 - SelectQuote, Inc. (0001794783) (Issuer)

    2/19/26 4:11:41 PM ET
    $SLQT
    Specialty Insurers
    Finance

    Chief Financial Officer Bentzen Edwin H Iv was granted 2,800 units of Common Stock - Series A, increasing direct ownership by 9% to 34,535 units (SEC Form 4)

    4 - Presidio Property Trust, Inc. (0001080657) (Issuer)

    2/19/26 3:05:57 PM ET
    $SQFT
    Real Estate Investment Trusts
    Real Estate

    $ALNA
    $AQST
    $ASO
    $AVCT
    Financials

    Live finance-specific insights

    View All

    Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results

    Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial results for the fourth quarter and full year ended December 31, 2025. Key highlights include: Record net sales of $143.1 million in Q4 2025 increased 36% year-over-year on a reported basis and 34% year-over-year on a constant currency basis. Glaucoma record net sales of $119.2 million in Q4 2025 increased 42% year-over-year. U.S. Glaucoma record net sales of $86.4 million in Q4 2025 increased 53% year-over-year. Net sales of $507.4 million in 2025 increased 32% yea

    2/17/26 4:05:00 PM ET
    $GKOS
    Medical/Dental Instruments
    Health Care

    UiPath Announces Fourth Quarter and Full Year Fiscal 2026 Financial Results Conference Call

    UiPath, Inc. (NYSE:PATH), a global leader in agentic automation, today announced it will report financial results for its fourth quarter and full year fiscal 2026 ended January 31, 2026 after the market closes on Wednesday, March 11, 2026. Management will host a conference call and webcast to discuss the Company's financial results at 5:00 pm ET. UiPath Fourth Quarter and Full Year Fiscal 2026 Financial Results Conference Call When: Wednesday, March 11, 2026 Time: 5:00 pm ET Conference ID: 13758276 Live Call: 1-877-407-8309 (US/Canada Toll-Free) or 1-201-689-8057 (Toll) Replay: A webcast replay of the conference call will be available on the investor relations website for one year. Webcas

    2/11/26 4:10:00 PM ET
    $PATH
    Computer Software: Prepackaged Software
    Technology

    Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress

    -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast today at 8:00 a.m. ET-- MIAMI, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2026 first quarter ended December 31, 2025, and provided a corporate update. "The strategy for the next generation of obesity drugs should be a combination therapy with GLP-1 receptor agonists for

    2/11/26 6:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNA
    $AQST
    $ASO
    $AVCT
    Leadership Updates

    Live Leadership Updates

    View All

    Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer

    Board-certified allergist and leading food allergy and anaphylaxis researcher joins Aquestive to support Anaphylm™ (dibutepinephrine) sublingual film NDA resubmission and pipeline WARREN, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Matthew Greenhawt, MD, MBA, MSc, as Chief Medical Officer, strengthening its leadership team as the Company prepares to resubmit its Anaphylm™ New Drug Application (NDA) to the United Stated Food and Drug Admi

    2/18/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases

    Seres has finalized the protocol for the Phase 2 study of SER-155 in patients undergoing allogeneic hematopoietic stem cell transplant (allo-HSCT) with the FDA and has advanced key study startup activities and will pause further investment, while efforts to seek funding for the study remain ongoing Company's runway extension actions, including reducing the workforce by approximately 30%, are expected to extend its cash runway through Q3 2026 Seres will focus on advancing development of its early-stage live biotherapeutic programs in Inflammatory and immune diseases and supporting the read-out of clinical results from the fully enrolled Investigator-sponsored SER-155 study in immune checkp

    2/12/26 7:00:00 AM ET
    $MCRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cineverse and GameStop Invite Fans to 'Return to Silent Hill' with Innovative Partnership featuring Mysterious Messages, Exclusive Rewards, In-Store Media & More

    Return to Silent Hill Hits Theaters Nationwide on January 23 – Buy Tickets Now LOS ANGELES and GRAPEVINE, Texas, Jan. 14, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), a next generation entertainment studio, and GameStop Corp. (NYSE:GME), are pulling out all the stops in anticipation of the January 23 wide theatrical release of Return to Silent Hill (returntosilenthillmovie.com).  The two companies are collaborating on an immersive marketing campaign for the new film, based on the visionary video game, SILENT HILL 2. Since January 7, fans who visit a participating GameStop ca

    1/14/26 3:02:00 PM ET
    $CNVS
    $GME
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Electronics Distribution

    $ALNA
    $AQST
    $ASO
    $AVCT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AMTD Digital Inc.

    SC 13G/A - AMTD Digital Inc. (0001809691) (Subject)

    11/14/24 9:33:22 PM ET
    $HKD
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

    SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

    11/14/24 7:31:47 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by Quoin Pharmaceuticals Ltd.

    SC 13G/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Subject)

    11/14/24 7:23:29 PM ET
    $QNRX
    Medical/Dental Instruments
    Health Care